Axiom Space Partners with Exobiosphere for Drug Discovery in Space, Expands International Space Missions
Axiom Space has announced a collaboration with Exobiosphere, a company focused on drug discovery, to leverage the unique microgravity environment of space for pharmaceutical research. This partnership aims to accelerate the development of new drugs by utilizing the International Space Station (ISS) as a research platform. Concurrently, Axiom Space continues to expand its private astronaut missions to the ISS, notably with the participation of Türkiye's first astronaut, Alper Gezeravci, on Axiom Mission 3. This mission underscores the growing international interest and cooperation in space exploration, with Türkiye and Italy actively collaborating in this domain. Axiom Space is also progressing with its ambitious plans to construct its own commercial space station, a significant step towards establishing a sustainable space economy before the anticipated retirement of the ISS. This initiative positions Axiom Space as a key player in the burgeoning private space sector, contributing to the broader competitio...